Data in Table 6 suggested that some proteins such as CRP, TF, APOC3, and VWF might inhibit MG development, while others (e.g., APOA2 and ITIH2) have potential promotional effects on MG progression. This evidence concerns the gene ITIH2 and myasthenia gravis.